Insider · CIK 0001613867

Behbahani Ali

Reports to the SEC for 23 companies · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001613867

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-18	BDTXBlack Diamond Therapeutics, Inc.A Award	Director	AAward	+7,707 sh	$1.93	+$14.9K	110,236
2026-09-17	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2026-09-17	CRSPCRISPR Therapeutics AGM Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$14.00	+$420K	30,316
2026-09-17	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−13.7K sh	$57.09	−$781K	16,637
2026-07-01	GLUEMonte Rosa Therapeutics, Inc.J Other	Director	JOther	−1M sh	—	—	6,692,298
2026-07-01	GLUEMonte Rosa Therapeutics, Inc.J Other	Director	JOther	+15K sh	—	—	15,000
2026-07-01	GLUEMonte Rosa Therapeutics, Inc.J Other	Director	JOther	−15K sh	—	—	0
2026-06-26	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2026-06-19	BDTXBlack Diamond Therapeutics, Inc.A Award	Director	AAward	+8,961 sh	$1.66	+$14.9K	102,529
2026-06-11	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25.8K sh	—	—	25,800
2026-06-10	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Director	AAward	+37K sh	—	—	37,000
2026-06-10	KRROKorro Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.7K sh	—	—	14,677
2026-06-05	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,011 sh	—	—	0
2026-04-28	Arcellx, Inc.U Disposition from Tender	Director	UDisposition from Tender	−2,706 sh	—	—	0
2026-04-28	Arcellx, Inc.U Disposition from Tender	Director	UDisposition from Tender	−1,925 sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.5K sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,174 sh	—	—	0
2026-03-20	BDTXBlack Diamond Therapeutics, Inc.A Award	Director	AAward	+6,919 sh	$2.15	+$14.9K	93,568
2026-03-10	KRROKorro Bio, Inc. · Pre-Funded WarrantsA Award	Director	AAward	+243K sh	$11.11	+$2.7M	242,945
2026-03-10	KRROKorro Bio, Inc.A Award	Director	AAward	+207K sh	$11.11	+$2.3M	1,297,893
2026-02-09	SGPSpyGlass Pharma, Inc.P Purchase	Director, 10% Owner	PPurchase	+938K sh	$16.00	+$15M	6,035,038
2026-02-09	SGPSpyGlass Pharma, Inc. · Series C-2 Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.37M sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−402K sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series D Preferred StockC Conversion	Director, 10% Owner	CConversion	−738K sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series C-1 Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.37M sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−955K sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	Director, 10% Owner	CConversion	+955K sh	—	—	954,990
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	Director, 10% Owner	CConversion	+738K sh	—	—	5,097,538
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	Director, 10% Owner	CConversion	+402K sh	—	—	1,357,263
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	Director, 10% Owner	CConversion	+1.37M sh	—	—	2,989,408
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	Director, 10% Owner	CConversion	+1.37M sh	—	—	4,359,576
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	Director, 10% Owner	CConversion	+1.62M sh	—	—	1,619,240
2026-02-09	SGPSpyGlass Pharma, Inc. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.62M sh	—	—	0
2026-02-05	SGPSpyGlass Pharma, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+27.4K sh	—	—	27,400
2025-12-12	BDTXBlack Diamond Therapeutics, Inc.A Award	Director	AAward	+5,208 sh	$2.76	+$14.4K	86,649
2025-10-02	NEUENeueHealth, Inc.S Sale	Director, 10% Owner	SSale	−280 sh	$6.75	−$1,890	787,979
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−189K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−372K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc.F Tax Payment	Director, 10% Owner	FTax Payment	−551 sh	$6.75	−$3,719.25	1,159,683
2025-10-02	NEUENeueHealth, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+189K sh	$0.01	+$1,891.95	788,259
2025-10-02	NEUENeueHealth, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+608K sh	$0.01	+$6,075.36	2,261,870
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award	Director, 10% Owner	AAward	+372K sh	—	—	372,255
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award	Director, 10% Owner	AAward	+186K sh	—	—	186,128
2025-10-02	NEUENeueHealth, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+186K sh	$0.01	+$1,861.28	674,830
2025-10-02	NEUENeueHealth, Inc.S Sale	Director, 10% Owner	SSale	−900 sh	$6.75	−$6,075	2,260,970
2025-10-02	NEUENeueHealth, Inc.F Tax Payment	Director, 10% Owner	FTax Payment	−182 sh	$6.75	−$1,228.5	2,384,873
2025-10-02	NEUENeueHealth, Inc. · Series A Convertible Perpetual Preferred StockD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−75K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc.F Tax Payment	Director, 10% Owner	FTax Payment	−276 sh	$6.75	−$1,863	674,554
2025-10-02	NEUENeueHealth, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−2.38M sh	—	—	0

Recent filings

Accepted (ET)
Sep 214
Behbahani Ali0001193125-26-396868
SEC(opens sec.gov)
Sep 214
Behbahani Ali0001193125-26-396944
SEC(opens sec.gov)
Sep 214
Behbahani Ali0001193125-26-396935
SEC(opens sec.gov)
Jul 64
Behbahani Ali0001193125-26-296490
SEC(opens sec.gov)
Jun 294
Behbahani Ali0001193125-26-288598
SEC(opens sec.gov)
Jun 224
Behbahani Ali0001193125-26-277553
SEC(opens sec.gov)
Jun 124
Behbahani Ali0001193125-26-269885
SEC(opens sec.gov)
Jun 114
Behbahani Ali0001193125-26-268018
SEC(opens sec.gov)
Jun 114
Behbahani Ali0001193125-26-267632
SEC(opens sec.gov)
Jun 94
Behbahani Ali0001193125-26-264382
SEC(opens sec.gov)
Apr 284
Behbahani Ali0001193125-26-187305
SEC(opens sec.gov)

Insider transactions

Recent filings

Companies

Address